TickerFacts.

Medinotec Inc. (MDNC): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$1.18M
Year ended 2026-02-28
$1.09M
Trailing 12 months to 2026-05-31
$3.27M2023-02-28: -$185.0K2024-02-29: $688.8K2025-02-28: $3.27M2026-02-28: $1.18M$1.18M
2023-02-28 EBITDA (USD) 2026-02-28
Period endedEBITDAChange YoYSource filing
2026-02-28$1.18M-64.0%2026-05-28, From 2025-03-01
2025-02-28$3.27M+374.1%2026-05-28, From 2024-03-01
2024-02-29$688.8Kn/m2025-05-29, From 2023-03-01
2023-02-28-$185.0Kn/a2024-07-05, From 2022-03-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Medinotec Inc. (MDNC)2026-02-28$1.18M-64.0%
Neuroone Medical Technologies Corp (NMTC)2025-09-30-$3.96Mn/m
InspireMD, Inc. (NSPR)2025-12-31$426.39M+73.0%
Nexgel, Inc. (NXGL)2025-12-31-$2.90Mn/m
Beyond Air, Inc. (XAIR)2026-03-31-$25.94Mn/m
INVO Fertility, Inc. (IVF)2025-12-31-$6.56Mn/m
Allurion Technologies, Inc. (ALUR)2025-12-31-$29.17Mn/m
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$18.59Mn/m
Cerenome, Inc. (CNSY)2025-12-31-$14.85Mn/m

Compare MDNC, NMTC, NSPR, NXGL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗